Surgical procedure Companions, Inc. (NASDAQ:SGRY) Q2 2025 Earnings Convention Name August 5, 2025 8:30 AM ET
Firm Members
David T. Doherty – Government VP & CFOJ. Eric Evans – CEO & Director
Convention Name Members
Albert J. William Rice – UBS Funding Financial institution, Analysis DivisionAndrew Mok – Barclays Financial institution PLC, Analysis DivisionBenjamin Hendrix – RBC Capital Markets, Analysis DivisionBenjamin Michael Rossi – JPMorgan Chase & Co, Analysis DivisionBenjamin Whitman Mayo – Leerink Companions LLC, Analysis DivisionBrian Gil Tanquilut – Jefferies LLC, Analysis DivisionJoanna Sylvia Gajuk – BofA Securities, Analysis DivisionSarah Elizabeth James – Cantor Fitzgerald & Co., Analysis DivisionTao Qiu – Macquarie ResearchZachary Haggerty – Unidentified CompanyKeyBanc Capital Markets – Unidentified Firm
Operator
Good day, and welcome to the Surgical procedure Companions, Inc. Second Quarter 2025 Earnings Convention Name. [Operator Instructions] Please observe this occasion is being recorded.
I’d now like to show the convention over to Dave Doherty, Chief Monetary Officer. Please go forward.
David T. Doherty
Good morning, and thanks for becoming a member of Surgical procedure Companions Second Quarter 2025 Earnings Name. I’m joined as we speak by Eric Evans, our CEO. Throughout this name, we are going to make forward-looking statements. There are danger elements that would trigger future outcomes to be materially completely different from these statements which are described on this morning’s press launch and the reviews we file with the SEC, every of which can be found on our company web site. The corporate doesn’t undertake any responsibility to replace these forward-looking statements. As well as, we reference sure monetary measures which are non-GAAP, which we imagine will be helpful in evaluating our efficiency. We reconcile these measures to essentially the most relevant GAAP measure on this morning’s press launch. With that, I’ll flip the decision over to Eric. Eric?
J. Eric Evans
